Published in Drug Week, June 10th, 2005
Aggregate gross proceeds to the company were approximately $3.37 million. In connection with the private placement, Senesco has agreed to file a registration statement on form S-3 to register the shares of common stock and the shares underlying the warrants.
Oppenheimer & Co. acted as the placement agent for this transaction.
Senesco takes its name from the scientific term for the aging of plant cells:...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.